Role of Concomitant Chemo radiotherapy in Advanced Head & Neck Cancer.

Authors

  • M HAFEEZ
  • SHAHARYAR ,
  • K SHABBIR
  • M FAROOQ
  • Z ALAUDDIN
  • E U REHMAN

DOI:

https://doi.org/10.21649/akemu.v11i2.4252

Keywords:

Concomitant chemo-radio therapy, head and neck.

Abstract

A prospective study was conducted at Clinical Oncology Department K.E Medical College/Mayo Hospital, Lahore from March, 2003 to February 2004 to evaluate the response in 25 eligible advanced irresectable head and neck cancer patients treated with concomitant chemo-radiotherapy. Male patients were 18(72%) in number and female were 7(28%). T2 lesions were treated with a total dose of 6500 cGy while T3 and T4 lesions were given a dose of 6500 - 7500 cGy in conventional fractions. Single agent, cisplatin (100 mg/m2) was given with radiation therapy. Thirteen (52%) patients had a complete response and 9 (36%) patients had partial response. Concomitant chemo-radiation therapy is a better option for irresectable stage III and IV head and neck cancers with manageable toxicities (Grade III and IV) in majority of the patients.

Published

2021-01-23

How to Cite

HAFEEZ, M. ., , S., SHABBIR, K. ., FAROOQ, M. ., ALAUDDIN, Z. ., & REHMAN, E. U. . (2021). Role of Concomitant Chemo radiotherapy in Advanced Head & Neck Cancer. Annals of King Edward Medical University, 11(2), 100-101. https://doi.org/10.21649/akemu.v11i2.4252

Issue

Vol. 11 No. 2 (2005): AKEMU

Section

Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments jspark@kemu.edu.pk

Most read articles by the same author(s)

> >>